TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · major macro event coming up
QNCX

Quince Therapeutics, Inc.

Healthcare · Biotechnology

29.30$ -7.5% vs. previous close Closing price · As of: Nov 5, 2026

Ownership

Ownership Structure

Who owns Quince Therapeutics, Inc. (QNCX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.8% of the shares are freely tradable; institutional investors hold 17.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 17.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 66.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 1Mio.

Largest Shareholders

Institutions

Institutions QNCX
Name Stake (%) Shares Change (%) Date
Ikarian Capital, LLC 0.36 72,251 +0.0 06/30/2026
Millennium Management LLC 0.35 70,779 +465.4 06/30/2026
Balyasny Asset Management LLC 0.34 69,967 +0.0 06/30/2026
Squadron Capital Management LLC 0.20 40,375 +0.0 06/30/2026
Shay Capital LLC 0.09 17,468 +97.0 06/30/2026
BOOTHBAY FUND MANAGEMENT, LLC 0.07 13,911 +0.0 06/30/2026
Jane Street Group LLC 0.06 12,642 +0.0 06/30/2026

Funds

Funds QNCX
Name Stake (%) Shares Change (%) Date
Fidelity Extended Market Index 0.53 5,356 +23.4 08/31/2026
Fidelity Series Total Market Index 0.12 1,248 -50.3 08/31/2026
Fidelity Total Market Index 0.11 1,147 +168.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?